ANTIVIRAL AGENTS IN HEPATITIS-B VIRUS TRANSFECTED CELL-LINES - INHIBITORY AND CYTOTOXIC EFFECT RELATED TO TIME OF TREATMENT

Citation
J. Kruining et al., ANTIVIRAL AGENTS IN HEPATITIS-B VIRUS TRANSFECTED CELL-LINES - INHIBITORY AND CYTOTOXIC EFFECT RELATED TO TIME OF TREATMENT, Journal of hepatology, 22(3), 1995, pp. 263-267
Citations number
22
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
01688278
Volume
22
Issue
3
Year of publication
1995
Pages
263 - 267
Database
ISI
SICI code
0168-8278(1995)22:3<263:AAIHVT>2.0.ZU;2-Y
Abstract
The antiviral and cytotoxic effects of ara-arabinoside monophosphate, 2',3', dideoxy-cytidine, ganciclovir, 9-2(-phosphonylmethoxyethyl) ade nine, 2',3'-dideoxy-3'-thiacytidine and recombinant interferon-alpha w ere studied using two human hepatitis B virus transfected hepatoma cel l lines, HepG2 2.2.15 and HE 611. After 9 days of exposure, starting o n day 3 after seeding, inhibition of extracellular HBV-DNA expressed a s ID50 was in the 0.1-1.0 mu M range for 2',3'-dideoxy-3'-thiacytidine and 9-2 (-phosphonyhmethoxyethyl) adenine and >10 mu M for dideoxy-cy tidine, ara-arabinoside monophosphate and ganciclovir in both cell lin es. At 2.500 U/ml recombinant interferon-alpha showed less than 20% in hibition in both cell lines. The HBV-DNA inhibitory effects of 2',3'-d ideoxy-3'-thiacytidine and 9-2(-phosphonylmethoxyethyl) adenine were a lso investigated after 1 and 3 days of exposure. In that setting ID50' s were 10 and 3.3 mu M for 2',3'-dideoxy-3'-thiacytidine and >100 and 30 mu M for 9-2(-phosphonylmethoxyethyl) adenine, respectively. No maj or inhibitory effect on hepatitis B surface antigen and hepatitis B e antigen secretion was observed for any agent in this study, except for 9-2(-phosphonylmethoxyethyl) adenine in HE 611 cells. Cytotoxicity me asured by inhibition of [H-3-methyl] deoxythymidine incorporation and expressed as CD50 on day 4 was in the 10-100 mu M range for ara-arabin oside monophosphate; in the 100-1000 mu M range for 9-2(-phosphonylmet hoxyethyl) adenine, ganciclovir and dideoxy-cytidine; and >1000 mu M f or 2',3'-dideoxy-3'-thiacytidine. This CD50 decreased considerably (7- 100 fold) when measured on day 12 for dideoxy-cytidine, ganciclovir, 9 -2(-phosphonylmethoxyethyl) adenine and 2',3'-dideoxy-3'-thiacytidine, but was similar for ara-arabinoside monophosphate. Since the order of antiviral HBV activity and cytotoxicity of nucleoside analogues was s imilar in the two transfected hepatoma cell lines, we conclude that 2' ,3'-dideoxy-3'-thiacytidine and 9-2(-phosphonylmethoxyethyl) adenine a re very potent inhibitors of HBV-DNA, with a longlasting effect. In vi ew of the progressive toxicity with continuous administration, intermi ttent administration might be an alternative mode of therapy.